Skip to content
Home/Companies/Biotech/BiVictriX Therapeutics
BT

BiVictriX Therapeutics

Biotech·UK·Active·10yr hold

BiVictriX Therapeutics is a biotech company, headquartered in UK.

Entry
2016
Hold
10yr
Status
Active
Est. EV
–

Who owns BiVictriX Therapeutics?

BiVictriX Therapeutics is currently owned by Development Bank of Wales through Development Bank of Wales (Balance Sheet) (2000 vintage), since 2016.

Hand-verified · updated 2026-05-29

Development Bank of Wales
Investor
Development Bank of Wales
Development Bank of Wales (Balance Sheet) · 2000 · Evergreen

Key facts

HQUK
SectorBiotech
StatusActive

More from Development Bank of Wales (Balance Sheet)

Other portfolio companies in the same fund.

Amotio
Active
MedTechUK· 2025
Freight Logistics Solutions
Exited 2025
LogisticsUK· 2021
Antiverse
Active
AI/MLUK· 2020
IQ Endoscopes
Active
MedTechUK· 2020
Creo Medical
Exited 2016
MedTechUK· 2012

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings